Brief: Mersana Therapeutics Q1 EPS USD -0.16
09/05/2024 12:00
May 09 (Reuters) - Mersana Therapeutics Q1 net income USD -19.306 million. * Q1 collaboration revenue USD 9.245 million
MRSN — Mersana Therapeutics News Story
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m